BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramachandran P, Matchett KP, Dobie R, Wilson-Kanamori JR, Henderson NC. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis. Nat Rev Gastroenterol Hepatol 2020;17:457-72. [PMID: 32483353 DOI: 10.1038/s41575-020-0304-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Xiang H, Xiang D, Xiao S, Xiang H, Xiao J, Ren H, Hu P, Liu H, Peng M. Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence. Chin Med 2022;17:23. [PMID: 35180857 DOI: 10.1186/s13020-022-00579-7] [Reference Citation Analysis]
2 Carter J, Wang S, Friedman SL. Ten Thousand Points of Light: Heterogeneity Among the Stars of NASH Fibrosis. Hepatology 2021;74:543-6. [PMID: 33724489 DOI: 10.1002/hep.31807] [Reference Citation Analysis]
3 Wernberg CW, Ravnskjaer K, Lauridsen MM, Thiele M. The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients. J Clin Med 2021;10:930. [PMID: 33804302 DOI: 10.3390/jcm10050930] [Reference Citation Analysis]
4 Barcena-Varela M, Lujambio A. The Endless Sources of Hepatocellular Carcinoma Heterogeneity. Cancers (Basel) 2021;13:2621. [PMID: 34073538 DOI: 10.3390/cancers13112621] [Reference Citation Analysis]
5 Ma L, Khatib S, Craig AJ, Wang XW. Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution. Semin Liver Dis 2021;41:321-30. [PMID: 34130336 DOI: 10.1055/s-0041-1729970] [Reference Citation Analysis]
6 Cheng ML, Nakib D, Perciani CT, MacParland SA. The immune niche of the liver. Clin Sci (Lond) 2021;135:2445-66. [PMID: 34709406 DOI: 10.1042/CS20190654] [Reference Citation Analysis]
7 Le C, Liu Y, López-Orozco J, Joyce MA, Le XC, Tyrrell DL. CRISPR Technique Incorporated with Single-Cell RNA Sequencing for Studying Hepatitis B Infection. Anal Chem 2021;93:10756-61. [PMID: 34328316 DOI: 10.1021/acs.analchem.1c02227] [Reference Citation Analysis]
8 Kitto LJ, Henderson NC. Hepatic Stellate Cell Regulation of Liver Regeneration and Repair. Hepatol Commun 2021;5:358-70. [PMID: 33681672 DOI: 10.1002/hep4.1628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kirkwood PM, Gibson DA, Smith JR, Wilson-Kanamori JR, Kelepouri O, Esnal-Zufiaurre A, Dobie R, Henderson NC, Saunders PTK. Single-cell RNA sequencing redefines the mesenchymal cell landscape of mouse endometrium. FASEB J 2021;35:e21285. [PMID: 33710643 DOI: 10.1096/fj.202002123R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Giraud J, Saleh M. Host-Microbiota Interactions in Liver Inflammation and Cancer. Cancers (Basel) 2021;13:4342. [PMID: 34503151 DOI: 10.3390/cancers13174342] [Reference Citation Analysis]
11 Loft A, Alfaro AJ, Schmidt SF, Pedersen FB, Terkelsen MK, Puglia M, Chow KK, Feuchtinger A, Troullinaki M, Maida A, Wolff G, Sakurai M, Berutti R, Ekim Üstünel B, Nawroth P, Ravnskjaer K, Diaz MB, Blagoev B, Herzig S. Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication. Cell Metab 2021;33:1685-1700.e9. [PMID: 34237252 DOI: 10.1016/j.cmet.2021.06.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Dam TV, Toft NI, Grøntved L. Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD. Cells 2022;11:870. [DOI: 10.3390/cells11050870] [Reference Citation Analysis]
13 Zeng T, Yu X, Chen Z. Applying artificial intelligence in the microbiome for gastrointestinal diseases: A review. J Gastroenterol Hepatol 2021;36:832-40. [PMID: 33880762 DOI: 10.1111/jgh.15503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yang W, He H, Wang T, Su N, Zhang F, Jiang K, Zhu J, Zhang C, Niu K, Wang L, Yuan X, Liu N, Li L, Wei W, Hu J. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. Hepatology 2021. [PMID: 34089528 DOI: 10.1002/hep.31987] [Reference Citation Analysis]
15 Wang J, Huang D, Yu H, Cheng Y, Ren H, Zhao Y. Developing tissue engineering strategies for liver regeneration. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.02.003] [Reference Citation Analysis]
16 Barreby E, Chen P, Aouadi M. Macrophage functional diversity in NAFLD — more than inflammation. Nat Rev Endocrinol. [DOI: 10.1038/s41574-022-00675-6] [Reference Citation Analysis]
17 Boulter L, Bullock E, Mabruk Z, Brunton VG. The fibrotic and immune microenvironments as targetable drivers of metastasis. Br J Cancer 2021;124:27-36. [PMID: 33239677 DOI: 10.1038/s41416-020-01172-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Hu L, Wu C. In silico analysis suggests disruption of interactions between HAMP from hepatocytes and SLC40A1 from macrophages in hepatocellular carcinoma. BMC Med Genomics 2021;14:128. [PMID: 34001107 DOI: 10.1186/s12920-021-00977-0] [Reference Citation Analysis]
19 Jia M, Zhang H, Qin Q, Hou Y, Zhang X, Chen D, Zhang H, Chen Y. Ferroptosis as a new therapeutic opportunity for nonviral liver disease. Eur J Pharmacol 2021;908:174319. [PMID: 34252441 DOI: 10.1016/j.ejphar.2021.174319] [Reference Citation Analysis]
20 Su Q, Kim SY, Adewale F, Zhou Y, Aldler C, Ni M, Wei Y, Burczynski ME, Atwal GS, Sleeman MW, Murphy AJ, Xin Y, Cheng X. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience 2021;24:103233. [PMID: 34755088 DOI: 10.1016/j.isci.2021.103233] [Reference Citation Analysis]
21 Calcagno DM, Chu A, Gaul S, Taghdiri N, Toomu A, Leszczynska A, Kaufmann B, Papouchado B, Wree A, Geisler L, Hoffman HM, Feldstein AE, King KR. NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH. Hepatology 2022. [PMID: 34997987 DOI: 10.1002/hep.32320] [Reference Citation Analysis]
22 Wan M, Han J, Ding L, Hu F, Gao P. Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis. Front Med (Lausanne) 2021;8:604894. [PMID: 33869241 DOI: 10.3389/fmed.2021.604894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zhang C, Yang M. Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion. Front Med (Lausanne) 2021;8:789859. [PMID: 34869507 DOI: 10.3389/fmed.2021.789859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ruan B, Duan JL, Xu H, Tao KS, Han H, Dou GR, Wang L. Capillarized Liver Sinusoidal Endothelial Cells Undergo Partial Endothelial-Mesenchymal Transition to Actively Deposit Sinusoidal ECM in Liver Fibrosis. Front Cell Dev Biol 2021;9:671081. [PMID: 34277612 DOI: 10.3389/fcell.2021.671081] [Reference Citation Analysis]
25 Ströbel S, Kostadinova R, Fiaschetti-Egli K, Rupp J, Bieri M, Pawlowska A, Busler D, Hofstetter T, Sanchez K, Grepper S, Thoma E. A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Sci Rep 2021;11:22765. [PMID: 34815444 DOI: 10.1038/s41598-021-01951-7] [Reference Citation Analysis]
26 Trivedi P, Wang S, Friedman SL. The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells. Cell Metab 2021;33:242-57. [PMID: 33232666 DOI: 10.1016/j.cmet.2020.10.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
27 Shu G, Yusuf A, Dai C, Sun H, Deng X. Piperine inhibits AML-12 hepatocyte EMT and LX-2 HSC activation and alleviates mouse liver fibrosis provoked by CCl4: roles in the activation of the Nrf2 cascade and subsequent suppression of the TGF-β1/Smad axis. Food Funct 2021;12:11686-703. [PMID: 34730139 DOI: 10.1039/d1fo02657g] [Reference Citation Analysis]
28 De Muynck K, Vanderborght B, Van Vlierberghe H, Devisscher L. The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 2021;10:2959. [PMID: 34831182 DOI: 10.3390/cells10112959] [Reference Citation Analysis]
29 Singanayagam A, Triantafyllou E. Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting. Front Immunol 2021;12:661182. [PMID: 33868313 DOI: 10.3389/fimmu.2021.661182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Richter ML, Deligiannis IK, Yin K, Danese A, Lleshi E, Coupland P, Vallejos CA, Matchett KP, Henderson NC, Colome-Tatche M, Martinez-Jimenez CP. Single-nucleus RNA-seq2 reveals functional crosstalk between liver zonation and ploidy. Nat Commun 2021;12:4264. [PMID: 34253736 DOI: 10.1038/s41467-021-24543-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ali ES, Rychkov GY, Barritt GJ. Targeting Ca2+ Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E2755. [PMID: 32987945 DOI: 10.3390/cancers12102755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Rosenthal SB, Liu X, Ganguly S, Dhar D, Pasillas MP, Ricciardelli E, Li RZ, Troutman TD, Kisseleva T, Glass CK, Brenner DA. Heterogeneity of HSCs in a Mouse Model of NASH. Hepatology 2021;74:667-85. [PMID: 33550587 DOI: 10.1002/hep.31743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
33 Xiao S, Deng Y, Shen N, Sun Y, Tang H, Hu P, Ren H, Peng M. Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug. Int Immunopharmacol 2021;101:108166. [PMID: 34628270 DOI: 10.1016/j.intimp.2021.108166] [Reference Citation Analysis]
34 Guo L, Yi X, Chen L, Zhang T, Guo H, Chen Z, Cheng J, Cao Q, Liu H, Hou C, Qi L, Zhu Z, Liu Y, Kong R, Zhang C, Zhou X, Zhang Z, Song T, Xue R, Zhang N. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma. Gastroenterology 2021:S0016-5085(21)03471-5. [PMID: 34481846 DOI: 10.1053/j.gastro.2021.08.052] [Reference Citation Analysis]
35 Ye X, Wei J, Yue M, Wang Y, Chen H, Zhang Y, Wang Y, Zhang M, Huang P, Yu R. Leveraging Single-Cell RNA-seq Data to Uncover the Association Between Cell Type and Chronic Liver Diseases. Front Genet 2021;12:637322. [PMID: 33763117 DOI: 10.3389/fgene.2021.637322] [Reference Citation Analysis]
36 Geh D, Leslie J, Rumney R, Reeves HL, Bird TG, Mann DA. Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35022608 DOI: 10.1038/s41575-021-00568-5] [Reference Citation Analysis]
37 Wang T, Yeh MM, Avigan MI, Pelosof L, Feldman GM. Deciphering the Dynamic Complexities of the Liver Microenvironment - Toward a Better Understanding of Immune-Mediated liver Injury Caused by Immune Checkpoint Inhibitors (ILICI). AAPS J 2021;23:99. [PMID: 34401948 DOI: 10.1208/s12248-021-00629-2] [Reference Citation Analysis]